![[PRESS RELEASE] Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days](https://thedailyreaders.com/wp-content/uploads/2022/07/PRESS-RELEASE-Newly-Published-Phase-3-Study-in-People-with.jpg)
VANCOUVER, British Columbia & MUMBAI, July 13, 2022–SaNOtize Research & Development Corp., (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, and Glenmark Pharmaceuticals Limited (“Glenmark”), a global, innovation-driven pharmaceutical company, today published results of a Phase 3 clinical trial in The Lancet Regional Health Southeast Asia, illustrating the effectiveness of nitric oxide nasal spray (NONS™) for the treatment of adult patients with COVID-19.
Read more here.
VANCOUVER, British Columbia & MUMBAI, July 13, 2022–SaNOtize Research & Development Corp., (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, and Glenmark Pharmaceuticals Limited (“Glenmark”), a global, innovation-driven pharmaceutical company, today published results of a Phase 3 clinical trial in The Lancet Regional Health Southeast Asia, illustrating the effectiveness of nitric oxide nasal spray (NONS™) for the treatment of adult patients with COVID-19.
Read more here.
![[Biolojic on i24] Israeli company programs antibodies to fight cancer](https://thedailyreaders.com/wp-content/uploads/2022/11/Biolojic-on-i24-Israeli-company-programs-antibodies-to-fight-cancer-360x180.jpg)
